Product Reports Resources Pricing Login Book a demo

Sophia Genetics

Biotech & Life Sciences · Saint-Sulpice, Switzerland · Founded 2011 · IPO 2021

Helps clinicians and physicians predict genetic diseases better

Valuation $473M
Revenue $93M

Investors

15 investors on Sophia Genetics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Fondation FIT
Series B+ 14 investors entered at this stage
Credit Suisse
Invoke Capital
Eurazeo
Pictet
360 Capital
EPFL Swiss Federal Polytechnic School of Lausanne
Alychlo
aMoon Fund
Hitachi
Marc Coucke
Swisscom Ventures
Generation Investment Management
Endeavour Vision
Balderton Capital

Global footprint

Where Sophia Genetics has talent and traffic

Workforce by country
27 countries with
team presence
🇨🇭 Switzerland45.7%
🇫🇷 France19.5%
🇺🇸 United States17%
🇮🇹 Italy2.8%
🇧🇷 Brazil2.2%
Top 5 of 27 shown
Web traffic by country
43K monthly visits
across markets
🇺🇸 United States26.7%
🇬🇧 United Kingdom14.7%
🇨🇭 Switzerland14%
🇫🇷 France5.6%
🇦🇺 Australia4.9%
Top 5 markets shown

Talent graph

The shape of Sophia Genetics's talent

Dealroom maps Sophia Genetics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

13 standout operatorsDealroom-flagged across the org
21 AI specialistsincl. 8 core researchers
517 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Sophia Genetics's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$8M patent portfolio · 22 active families

Estimated portfolio value
$8M
1.7% of market cap · 90.8× larger than top peer Immunai ($90k)
22 active patent families
Where Sophia Genetics innovates BioinformaticsComputational biologyDNAData miningGenomic data

Where Sophia Genetics concentrates vs peers

Each axis is a top-10 topic across Sophia Genetics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Sophia Genetics

An AI-synthesized read of the highest-engagement posts about Sophia Genetics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sophia Genetics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.